When Blood Transfusion Is Not an Option: Yale Neuro-ICU Successfully Administers Transfusion Replacement Therapy
The Yale New Haven neuro-ICU has successfully administered a transfusion replacement therapy, which benefits patients with aneurysmal subarachnoid hemorrhage (SAH), as well as those with severe anemia from blood loss and critical illness.
Triage Standards During Pandemic May Worsen Racial Disparities in Treatment
Two Yale-led studies suggest that a standard measurement designed to help predict which patients have the best chances of survival—and who therefore should receive treatment—could promote racial disparities of treatment outcomes.Source: YaleNews
Yale School of Medicine starting trials on new epilepsy treatment that uses smart technology
About one-third of people diagnosed with epilepsy are not able to get relief from treatments currently available. Now, researchers at Yale University School of Medicine and two other locations are beginning trials on a new and innovative treatment that uses smart technology.Source: WTNH News 8
What to Do About Aducanumab? Academic Memory Programs Brace for the Tough Questions
Academic medical centers are establishing committees and workgroups to develop standards and criteria for determining eligibility for the newly-approved and controversial Alzheimer's drug, aducanumab.Source: NeurologyToday
The unexplained disorder: A test of stigma, ethics and empathy
The diagnosis and treatment of difficult-to-measure disorders have long been complicated by stigma from health professionals, the public and even patients themselves. In fact, patients with medically unexplained symptoms, including functional neurological disorders—like fibromyalgia, chronic fatigue syndrome and chronic pain syndromes—are often dismissed as hysterical, deceitful, even dangerous.Source: American Medical Association
Storms like Elsa bring low-pressure systems that may cause migraines; Yale doctor talks advances in treating, prevention
Storms like Tropical Storm Elsa that hit Connecticut this week bring low-pressure systems that, for some, trigger migraine headaches. A Yale Medicine doctor who treats headaches joined us Friday to talk about the advances in treating and preventing migraines.Source: News 8
Science Communication Week highlights underrepresented voices and unconventional paths
Virtual talks from communicators underrepresented in science are underway as part of Science Communication Week, one of many efforts from the Yale Biological and Biomedical Sciences Diversity and Inclusion Collective (YBDIC) to make science accessible and relevant to minoritized students.
Yale Cancer Center and Smilow Cancer Hospital physicians recognized as Connecticut Magazine 'Best Doctors'
Connecticut Magazine has named 90 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2021 Best Doctors guide. Published in the magazine’s June issue, the 'Best Doctors' list consists of more than 1,500 Connecticut physicians from nearly 40 medical specialties.
YSM Dean’s Workshop Highlights Collaborative Future of Genomic Healthcare
Yale School of Medicine’s Dean’s Office hosted a workshop to introduce the Yale Center for Genomic Health (YCGH) to the Yale community. It was an event that brought together scholars and professionals from across diverse disciplines to learn more about the science of genomic healthcare and the vision of the YCGH.
Connecticut's Top Doctors 2021: Over 1,500 physicians in 66 specialties
Finding a great physician can be difficult. That’s why we’ve partnered with Castle Connolly, a leading national health care research company, to bring you our biggest guide ever to Connecticut’s most recommended health practitioners. Here are the results of the doctor-voted survey.Source: Connecticut Magazine
$3.59M NIMH Grant Awarded to Serena Spudich, MD
A new, five-year, $3.59M grant from the National Institute of Mental Health (NIMH) was awarded to Principal Investigator Serena Spudich, MD, Gilbert Glaser Professor of Neurology at Yale, along with co-PI, Joshua Cyktor, PhD, of the University of Pittsburgh.